Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence

By LabMedica International staff writers
Posted on 29 Jan 2024

The global healthcare industry is increasingly embracing Artificial Intelligence (AI) to drive scientific breakthroughs, create new treatments, and enhance health outcomes for a wide range of medical conditions. Medlab Middle East, an event organized by Informa Markets Healthcare (London, UK), is set to explore AI's crucial role in laboratories. Experts will converge for the 23rd edition of Medlab Middle East from February 5-8 at the Dubai World Trade Centre where the focus will be on revolutionizing laboratory medicine and introducing sustainable solutions. A new show vertical, in partnership with Express Med Diagnostics and Research (Manama, Bahrain), will spotlight Next Generation medicine, featuring product categories like technology, innovation, general services, imaging, infrastructure, IT, laboratory, medical equipment, pharma, and nutrition.

AI's application in medical imaging is witnessing an increase in the UAE, bolstered by several government initiatives. In Dubai, healthcare organizations are effectively utilizing AI for medical imaging, including automated detection of breast cancer and lung diseases. Saudi Arabia recently introduced the country's first AI-powered eye screening tests for diabetic retinopathy, enhancing diagnostic accuracy and efficiency. AI is also expediting the discovery of new medicines in the region by simulating trial-and-error processes in a computer to determine optimal drug compositions. In October 2023, the UAE launched its first Centre for Excellence (COE) in AI, providing services like an organ donation and transplant center. This facility leverages AI to match donors with patients and prioritize urgent cases, both domestically and internationally. The Centre is also planning to deploy AI for analyzing radiological scans, aiming to improve diagnostic efficiency. An AI lab is expected to launch soon at the Centre.

Professor Hassan Ugail, Director of the Centre for Visual Computing and Intelligent Systems at the University of Bradford (Bradford, UK), is scheduled to speak at Medlab Middle East as part of the ‘Digitalization, Automation and Innovation’ session, on the second day of the NextGen Conference. Professor Ugail has been responsible for leading the development of a pioneering AI tool called “OrQA” (Organ Quality Assessment), which examines the quality of human organs for transplantation. Time is a critical factor when it comes to evaluating organs for transplantation. OrQA can provide detailed and reliable analysis in just seconds. The AI method uses a scoring system to grade an organ between zero and five, with organs that score below four, being suitable for use. There are plans to take the tool worldwide in the coming year.

“We use state-of-the-art artificial intelligence techniques to train a machine learning algorithm and worked with a number of surgeons to ‘score’ a range of organs. The machine then learns about the scores, alongside other characteristics such as the color, texture and shape of the organ,” said Professor Ugail. “Traditionally when an organ becomes available for transplantation, you need to gather experts as quickly as possible for an assessment. With OrQA, an image of that organ can be uploaded and it will quickly provide a score. It is an excellent application of AI for real healthcare use and helps surgeons to make the best possible decisions in the quickest possible time.”

“The integration of AI into laboratory practices is already redefining the landscape of scientific discovery and driving innovation in healthcare. In the years to come, the need for AI in medical imaging will continue to grow,” added Tom Coleman, Exhibition Director, Informa Markets Healthcare. “AI technologies are able to process and analyze data more quickly and accurately leading to new insights in various realms of study, and we are excited to spotlight this exciting field of healthcare at Medlab Middle East.”

Related Links:
Informa Markets Healthcare
Express Med Diagnostics and Research
University of Bradford

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Amoebiasis Test
ELI.H.A Amoeba
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.